Total vascular exclusion technique for resection of hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

203

HTML

1839

Tables (1-4)

116

Sum=2158

Oct 15, 2003 (publication date) through Jun 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Oct 15, 2003; 9(10): 2194-2197
Published online Oct 15, 2003. doi: 10.3748/wjg.v9.i10.2194

Table 1 General clinical data

^aP < 0.05 vs statistically significant when compared with group B.

Table 2 Pathologic data

Clinical parameters	Group A (n = 78)	Group B (n = 176)
The mass
Median diameter (cm)	11.58 (6.2-24.6)^a	6.25 (1.8-12.7)
> or = 5 cm	72 (92.30%)^a	118 (67.05%)
> or = 10 cm	53 (67.95%)^a	28 (15.90%)
Close or invade vana cana	23 (29.49%)^a	17 (9.65%)
Close or invade major	21 (26.92%)^a	13 (7.39%)
hepatic vein
Close or invade major bile duct	11 (14.10%)^a	8 (4.55%)
Close or invade major port vein	32 (41.03%)^a	22 (12.5%)
TNM tumor stage
Stage 1	6 (7.69%)^a	49 (27.84%)
Stage 2	12 (15.38%)^a	71 (40.34%)
Stage 3	36 (46.15%)^a	32 (18.19%)
Stage 4a	20 (25.64%)^a	22 (12.5%)
Stage 4b	4 (5.13%)^a	2 (1.14%)
Cirrhosis	59 (75.64%)	120 (68.18%)
Multiple tumor	8 (10.25%)^a	6 (3.41%)
Caudate lobe tumor	4 (5.13%)^a	0 (0)
Tumor free resection margin	74 (94.87%)	173 (98.3%)
Tumor rupture during operation	11 (14.10%)^a	13 (7.39%)

^aP < 0.05 vs statistically significant when compared with group B.

Table 3 Postoperative complications

Clinical parameters	Group A	Group B
Bleeding	16 (20.51%)	29 (16.48%)
Bile leakage	6 (7.69%)^a	8 (4.55%)
Infection (including abscess)	12 (15.38%)	23 (13.68)
Pleural effusion	31 (39.74%)^a	34 (19.32%)
Reoperation within 24 h	3 (3.85%)	6 (3.40%)
after operation
Ascites	16 (20.51%)^a	20 (11.36%)
Jaundice	6 (7.69%)^a	5 (2.84%)
Hepatic failure	6 (7.69%)^a	5 (2.84%)
Total morbidity	40 (51.28%)^a	45 (25.57%)
Perioperative mortality	2 (2.56%)	5 (2.84%)

^aP < 0.05 vs statistically significant when compared with group B.

Table 4 Outcome after hepatic resection

^aP < 0.05 vs statistically significant when compared with group B;

^bP < 0.05 vs statistically significant when compared with group C.

Citation: Yin ZY, Wang XM, Yu RX, Zhang BM, Yu KK, Li N, Li JS. Total vascular exclusion technique for resection of hepatocellular carcinoma. World J Gastroenterol 2003; 9(10): 2194-2197
URL: https://www.wjgnet.com/1007-9327/full/v9/i10/2194.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i10.2194